Cargando…
ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects
BACKGROUND: The literature contains conflicting results regarding the status of serum anti-Aβ antibody concentrations in Alzheimer's disease (AD). Reduced levels of these antibodies have been suggested to contribute to the development of this disorder. The conflicting results may be due to poly...
Autores principales: | Klaver, Andrea C, Coffey, Mary P, Smith, Lynnae M, Bennett, David A, Finke, John M, Dang, Loan, Loeffler, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162899/ https://www.ncbi.nlm.nih.gov/pubmed/21827691 http://dx.doi.org/10.1186/1742-2094-8-93 |
Ejemplares similares
-
Biophysical characterization data on Aβ soluble oligomers produced through a method enabling prolonged oligomer stability and biological buffer conditions
por: Crisostomo, Amanda C., et al.
Publicado: (2015) -
Cognitive and noncognitive predictors of success
por: Duckworth, Angela L., et al.
Publicado: (2019) -
Prevention and treatment of noncognitive complications
por: van Zundert, André, et al.
Publicado: (2023) -
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
por: Klaver, Andrea C., et al.
Publicado: (2017) -
Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)